COVID-19 in Pregnancy
Submission Deadline: 31 Aug 2023
Guest Editor
Department of Life Sciences, Health, and Health Care Professions, Link Campus University, Rome, Italy
Interests: gynaecopathology; gynaecological oncology; molecular oncology; human papilloma virus; PAP smear; breast cancer; target therapy; precision oncology; endocrine disruptors; SIDS; COVID-19
Special Issue in IMR Press journals
Special Issue in COVID-19 in Pregnancy - Volume II
Special Issue Information
Dear Colleagues,
It was 11 March 2020, when the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic, which would later shock the entire globe. Among the people most vulnerable to infection are pregnant women due to rearrangements in the immune and angiotensin systems. To combat COVID-19, specific and innovative vaccines have been launched in record time by conditional marketing authorization, whose long-term effects on the mother, fetus and newborn are not yet known. There are still limited data on the implications of COVID-19 infections for labor, although an increased risk of preterm delivery has been reported. Early studies indicated no evidence for vertical mother-to-child transmission of COVID-19 in late pregnancy, but more recent findings show that vertical transmission can occur in some cases. The aim and scope of this Special Issue is therefore to collect as much up-to-date information as possible on COVID-19 in pregnancy through a multidisciplinary approach.
Dr. Luca Roncati
Guest Editor
Keywords
- COVID-19
- SARS-CoV-2
- Th1
- Th2
- ACE
- ACE2
- angiotensin
- pregnancy
- preterm labor
- miscarriage
- placenta
- fetus
- fetoplacental pathology
- vaccines
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (3)
Obstetric Outcomes during COVID-19 Pandemic: Vaccination and Infection in Pregnancy
Clin. Exp. Obstet. Gynecol. 2024, 51(1), 13; https://doi.org/10.31083/j.ceog5101013
(This article belongs to the Special Issue COVID-19 in Pregnancy)
Perinatal Care during the COVID-19 Pandemic
Clin. Exp. Obstet. Gynecol. 2023, 50(3), 51; https://doi.org/10.31083/j.ceog5003051
(This article belongs to the Special Issue COVID-19 in Pregnancy)
The Psychological Impacts of COVID-19 Pandemics on Pregnant Women in Hong Kong—Results of a Web-Based Cross-Sectional Survey
Clin. Exp. Obstet. Gynecol. 2023, 50(2), 35; https://doi.org/10.31083/j.ceog5002035
(This article belongs to the Special Issue COVID-19 in Pregnancy)